David Malkin, MD

For unparalleled contributions to the understanding of pediatric cancer genetic predisposition syndromes, elucidating the role of germline TP53 mutations in Li-Fraumeni syndrome, optimizing pediatric cancer patient clinical surveillance protocols, and improving precision pediatric oncology through novel clinical trials involving adolescents and young adults with rare and difficult to treat cancers.

*Full-length biography pending